As nanotechnology-based breath analysis advances, its applications should extend beyond T1DM to address other ketotic states, including those triggered by ketogenic diets, fasting, and medications like SGLT2 inhibitors. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.